PubMed:8376413
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-62 | Sentence | denotes | Structural prerequisites for serum amyloid A fibril formation. |
| T2 | 63-199 | Sentence | denotes | Most studies of experimental amyloid A protein (AA) amyloidosis in mice have been performed in type A mice with BALB/c as the prototype. |
| T3 | 200-321 | Sentence | denotes | In these mice the products of two genes, SAA1 and SAA2, are the major apo-SAA isoforms on high density lipoprotein (HDL). |
| T4 | 322-444 | Sentence | denotes | Of these two isoforms, that differ at nine amino acids, only apo-SAA2 is rapidly cleared and deposited as amyloid fibrils. |
| T5 | 445-529 | Sentence | denotes | No mouse strain has ever been shown to be completely resistant to amyloid induction. |
| T6 | 530-613 | Sentence | denotes | We have found the CE/J mouse strain to be exceedingly resistant to amyloidogenesis. |
| T7 | 614-755 | Sentence | denotes | Data indicate that this resistance is not due to a lack of apo-SAA synthesis but rather resides in the unique apo-SAA isoform in this strain. |
| T8 | 756-841 | Sentence | denotes | CE/J mice have a single major apo-SAA isoform (pI 6.15) the product of a single gene. |
| T9 | 842-963 | Sentence | denotes | This is a hybrid molecule with features of both apo-SAA1 and apo-SAA2, differing from the latter at only six amino acids. |
| T10 | 964-1219 | Sentence | denotes | When CD studies were performed to explore the structural relationship of this isoform to apo-SAA1 and apo-SAA2, we found that when bound to heparan sulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta-sheet folding typical for apo-SAA2. |
| T11 | 1220-1345 | Sentence | denotes | This evidence suggests that the folding effect of heparan sulfate proteoglycan on apo-SAA2 is important in amyloid formation. |
| T1 | 0-62 | Sentence | denotes | Structural prerequisites for serum amyloid A fibril formation. |
| T2 | 63-199 | Sentence | denotes | Most studies of experimental amyloid A protein (AA) amyloidosis in mice have been performed in type A mice with BALB/c as the prototype. |
| T3 | 200-321 | Sentence | denotes | In these mice the products of two genes, SAA1 and SAA2, are the major apo-SAA isoforms on high density lipoprotein (HDL). |
| T4 | 322-444 | Sentence | denotes | Of these two isoforms, that differ at nine amino acids, only apo-SAA2 is rapidly cleared and deposited as amyloid fibrils. |
| T5 | 445-529 | Sentence | denotes | No mouse strain has ever been shown to be completely resistant to amyloid induction. |
| T6 | 530-613 | Sentence | denotes | We have found the CE/J mouse strain to be exceedingly resistant to amyloidogenesis. |
| T7 | 614-755 | Sentence | denotes | Data indicate that this resistance is not due to a lack of apo-SAA synthesis but rather resides in the unique apo-SAA isoform in this strain. |
| T8 | 756-841 | Sentence | denotes | CE/J mice have a single major apo-SAA isoform (pI 6.15) the product of a single gene. |
| T9 | 842-963 | Sentence | denotes | This is a hybrid molecule with features of both apo-SAA1 and apo-SAA2, differing from the latter at only six amino acids. |
| T10 | 964-1219 | Sentence | denotes | When CD studies were performed to explore the structural relationship of this isoform to apo-SAA1 and apo-SAA2, we found that when bound to heparan sulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta-sheet folding typical for apo-SAA2. |
| T11 | 1220-1345 | Sentence | denotes | This evidence suggests that the folding effect of heparan sulfate proteoglycan on apo-SAA2 is important in amyloid formation. |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1104-1119 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
| T2 | 1270-1285 | http://www.glycoepitope.jp/epitopes/EP0086 | denotes | heparan sulfate |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 35-42 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T2 | 92-99 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T3 | 110-126 | Disease | denotes | (AA) amyloidosis | http://purl.obolibrary.org/obo/MONDO_0019439 |
| T4 | 428-435 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T5 | 511-518 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
| T6 | 1327-1334 | Disease | denotes | amyloid | http://purl.obolibrary.org/obo/MONDO_0019065 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 110-126 | Phenotype | denotes | (AA) amyloidosis | HP:4000041 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 130-134 | Organism | denotes | mice | 10088 |
| T2 | 165-169 | Organism | denotes | mice | 10088 |
| T3 | 209-213 | Organism | denotes | mice | 10088 |
| T4 | 448-453 | Organism | denotes | mouse | 10088|10090 |
| T6 | 553-558 | Organism | denotes | mouse | 10088|10090 |
| T8 | 761-765 | Organism | denotes | mice | 10088 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 110-126 | Phenotype | denotes | (AA) amyloidosis | HP:4000041 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-62 | Sentence | denotes | Structural prerequisites for serum amyloid A fibril formation. |
| T2 | 63-199 | Sentence | denotes | Most studies of experimental amyloid A protein (AA) amyloidosis in mice have been performed in type A mice with BALB/c as the prototype. |
| T3 | 200-321 | Sentence | denotes | In these mice the products of two genes, SAA1 and SAA2, are the major apo-SAA isoforms on high density lipoprotein (HDL). |
| T4 | 322-444 | Sentence | denotes | Of these two isoforms, that differ at nine amino acids, only apo-SAA2 is rapidly cleared and deposited as amyloid fibrils. |
| T5 | 445-529 | Sentence | denotes | No mouse strain has ever been shown to be completely resistant to amyloid induction. |
| T6 | 530-613 | Sentence | denotes | We have found the CE/J mouse strain to be exceedingly resistant to amyloidogenesis. |
| T7 | 614-755 | Sentence | denotes | Data indicate that this resistance is not due to a lack of apo-SAA synthesis but rather resides in the unique apo-SAA isoform in this strain. |
| T8 | 756-841 | Sentence | denotes | CE/J mice have a single major apo-SAA isoform (pI 6.15) the product of a single gene. |
| T9 | 842-963 | Sentence | denotes | This is a hybrid molecule with features of both apo-SAA1 and apo-SAA2, differing from the latter at only six amino acids. |
| T10 | 964-1219 | Sentence | denotes | When CD studies were performed to explore the structural relationship of this isoform to apo-SAA1 and apo-SAA2, we found that when bound to heparan sulfate proteoglycan the CE/J pI 6.15 isoform fails to undergo the beta-sheet folding typical for apo-SAA2. |
| T11 | 1220-1345 | Sentence | denotes | This evidence suggests that the folding effect of heparan sulfate proteoglycan on apo-SAA2 is important in amyloid formation. |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 35-42 | Disease | denotes | amyloid | MONDO:0019065 |
| T2 | 92-99 | Disease | denotes | amyloid | MONDO:0019065 |
| T3 | 110-126 | Disease | denotes | (AA) amyloidosis | MONDO:0019439 |
| T4 | 428-435 | Disease | denotes | amyloid | MONDO:0019065 |
| T5 | 465-469 | Disease | denotes | ever | MONDO:0009176 |
| T6 | 511-518 | Disease | denotes | amyloid | MONDO:0019065 |
| T7 | 1327-1334 | Disease | denotes | amyloid | MONDO:0019065 |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 1104-1119 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
| T2 | 1270-1285 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 45-51 | Body_part | denotes | fibril | http://purl.obolibrary.org/obo/GO_0099512 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 29-34 | Body_part | denotes | serum | FMA:63083 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 130-134 | OrganismTaxon | denotes | mice | 10088 |
| T2 | 165-169 | OrganismTaxon | denotes | mice | 10088 |
| T3 | 209-213 | OrganismTaxon | denotes | mice | 10088 |
| T4 | 448-453 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T6 | 553-558 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T8 | 761-765 | OrganismTaxon | denotes | mice | 10088 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 45-51 | Body_part | denotes | fibril | http://purl.obolibrary.org/obo/GO_0099512 |